Resting Magnetoencephalography Alterations in Severe Mental Illnesses: A Systematic Review

Schizophrenia, major depressive disorder (MDD), and bipolar disorder (Severe Mental Illnesses: SMIs), share genetic risk and brain structure, but their neural mechanisms remain unclear. Magnetoencephalography (MEG), with millisecond precision, enables direct examination of shared and disorder-specific disturbances in neural timing. We reviewed resting-state MEG evidence on spectral power, connectivity, information-theoretic complexity, and brain dynamics across SMIs.A comprehensive search yielded 62 studies. Three reviewers screened, retrieved, and extracted data on MEG-related variables across regional activity (power), coordination of activity (connectivity, coherence, synchrony), regularity of activity (complexity, entropy), and overall dynamics.Three principal findings emerged. Beta oscillations emerge as the most consistently replicated transdiagnostic signal across separate disorder-specific studies, with increased power across all three disorders and correlating with hallucinations, sleep disturbances, and cognitive deficits, consistent with disrupted predictive processing. Preliminary evidence emerges that complexity–age dissociation may partition SMIs into neuroprogressive and state-dependent trajectories: neural complexity declines with age in schizophrenia and bipolar disorder (opposite to healthy aging), while depression preserves the normative trajectory. Slow-wave activity diverges sharply: schizophrenia shows a widespread increase characteristic of cortical ‘idling,’ while mood disorders show a decrease characteristic of ‘restlessness.’We propose a temporal disorganisation spectrum from excessive fragmentation (schizophrenia) to pathological rigidity (depression), with bipolar disorder occupying an intermediate position. This framework offers biomarker-type utility for stratifying illness severity, tracking neuroprogression, and identifying transdiagnostic therapeutic targets, particularly beta-modulatory neuromodulation interventions applicable across SMIs.